These include upregulation of MHC I on APCs and expression of tumor cell antigens (30, 31), differentiation of CD8+ T cells into cytolytic effector cells (32), downregulation of T regulatory cells (33), reduction in IL-12p40 (34), and upregulation of IL15 together with further lymphocyte expansion (30). The gene discussed is CD8A; the disease is neoplasm.